Impact of 6 months’ Use of Intermittently Scanned Continuous Glucose Monitoring on Habitual Sleep Patterns and Sleep Quality in Adolescents and Young Adults with Type 1 Diabetes and High-Risk HbA1c

Pediatr DiabetesPublished Randomised controlled trial

Authors' conclusion

The use of first-generation isCGM in addition to finger-prick testing did not impact objective or subjective sleep measures in AYA with T1D, elevated HbA1c, and highly variable sleep patterns. Research using alternative interventions for improving glycemic outcomes and habitual sleep-wake timing, duration, and perceived sleep quality is warranted in this population group.

Study context

Population
Adolescents and young adults aged 13–20 years with T1D and HbA1c ≥ 75 mmol/mol; mean age 16.6 ± 2.1, 48% female, 41% Māori or Pasifika, mean HbA1c 96.0 ± 18.0 mmol/mol
Participants
64 adolescents
Comparison
isCGM plus SMBG vs SMBG
  • isCGM + SMBGn = 33
  • SMBGn = 31reference
Primary endpoint
Habitual sleep and wake timing, sleep duration, night-time awakenings, sleep efficiency and perceived sleep quality (actigraphy and Pittsburgh Sleep Quality Index)
Follow-up
6 months

Primary result

As reported in the abstract

Sleep measures (Pittsburgh Sleep Quality Index and actigraphy)
  • Subjective overall sleep quality, latency, duration, efficiency, night-time disturbances, sleep medication use and daytime dysfunction were similar between the groups
  • No significant differences in actigraphy-measured sleep timing and duration across the week
  • Adjusted for age, period of the school year and baseline sleep values

Original publication

Impact of 6 months’ Use of Intermittently Scanned Continuous Glucose Monitoring on Habitual Sleep Patterns and Sleep Quality in Adolescents and Young Adults with Type 1 Diabetes and High-Risk HbA1c. Pediatr Diabetes. Published 28 March 2023. doi:10.1155/2023/1842008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.